Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amaryl M vs Amaryl + Lantus in T2DM
NCT00913367Phase 4Completed
- Sponsor
- Handok
- Start
- May 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of glimepiride + metformin in type 2 diabetes mellitus (T2DM), sponsored by Handok. Started May 2009; status: completed.
02
Drugs
glimepiride + metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00913367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00913367.